Venous Thromboembolism in Rheumatoid Arthritis: The Added Effect of Disease Activity to Traditional Risk Factors.

IF 1.7 Q3 RHEUMATOLOGY
Open Access Rheumatology-Research and Reviews Pub Date : 2022-10-17 eCollection Date: 2022-01-01 DOI:10.2147/OARRR.S284757
Mohammed A Omair, Sara A Alkhelb, Sadeen E Ezzat, Ayah M Boudal, Mohammed K Bedaiwi, Ibrahim Almaghlouth
{"title":"Venous Thromboembolism in Rheumatoid Arthritis: The Added Effect of Disease Activity to Traditional Risk Factors.","authors":"Mohammed A Omair,&nbsp;Sara A Alkhelb,&nbsp;Sadeen E Ezzat,&nbsp;Ayah M Boudal,&nbsp;Mohammed K Bedaiwi,&nbsp;Ibrahim Almaghlouth","doi":"10.2147/OARRR.S284757","DOIUrl":null,"url":null,"abstract":"<p><p>Many epidemiological studies have shown an increased risk of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA). RA and VTE share some background factors, such as increasing age, smoking, and obesity. At the same time, other VTE factors, such as knee replacement and oral contraceptive pills, occur commonly in RA patients. In addition, the chronic inflammatory state of RA might hypothetically lead to endothelial injury and a hypercoagulable state. Two critical pathophysiological pathways lead to VTE. Recently, concerns increased about the increased risk of VTE in patients using Janus Kinase inhibitors. This review aims at reviewing the risk of VTE in RA and the role of traditional risk factors and disease-related inflammation and develops a conceptual framework that describes the interaction between these factors.</p>","PeriodicalId":45545,"journal":{"name":"Open Access Rheumatology-Research and Reviews","volume":" ","pages":"231-242"},"PeriodicalIF":1.7000,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/0d/oarrr-14-231.PMC9586712.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Access Rheumatology-Research and Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/OARRR.S284757","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 4

Abstract

Many epidemiological studies have shown an increased risk of venous thromboembolism (VTE) in patients with rheumatoid arthritis (RA). RA and VTE share some background factors, such as increasing age, smoking, and obesity. At the same time, other VTE factors, such as knee replacement and oral contraceptive pills, occur commonly in RA patients. In addition, the chronic inflammatory state of RA might hypothetically lead to endothelial injury and a hypercoagulable state. Two critical pathophysiological pathways lead to VTE. Recently, concerns increased about the increased risk of VTE in patients using Janus Kinase inhibitors. This review aims at reviewing the risk of VTE in RA and the role of traditional risk factors and disease-related inflammation and develops a conceptual framework that describes the interaction between these factors.

Abstract Image

类风湿关节炎的静脉血栓栓塞:疾病活动对传统危险因素的附加影响。
许多流行病学研究表明,类风湿关节炎(RA)患者发生静脉血栓栓塞(VTE)的风险增加。类风湿性关节炎和静脉血栓栓塞有一些共同的背景因素,如年龄增长、吸烟和肥胖。同时,其他静脉血栓栓塞因素,如膝关节置换术和口服避孕药,也常见于RA患者。此外,风湿性关节炎的慢性炎症状态可能导致内皮损伤和高凝状态。两个关键的病理生理途径导致静脉血栓栓塞。最近,人们越来越关注使用Janus激酶抑制剂的患者发生静脉血栓栓塞的风险增加。本综述旨在回顾类风湿关节炎中静脉血栓栓塞的风险以及传统危险因素和疾病相关炎症的作用,并建立一个描述这些因素之间相互作用的概念框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
34
审稿时长
16 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信